06th November 2025 | 10:00am EST / 7:00am PST / 3:00pm GMT / 4:00pm CET | Scott Mangiacotti, Sr. Director, Automation Solutions at Cytiva |WATCH FOR FREE
Join Scott Mangiacotti, Senior Director, Automation Solutions at Cytiva, for a webinar on using pre-engineered, process-ready solutions to transform how automation is deployed and scaled across your operations. Compatible with leading industrial automation platforms, these pre-engineered solutions are built on open standards and are digitally enabled to support cloud connectivity, advanced process control (APC), and process analytical technologies (PAT).
We’ll explore how productized, scalable designs can help you reduce project timelines, lower total cost of ownership, and minimize implementation risks—all while maintaining performance and flexibility. Whether you’re planning a new automation project or enhancing existing infrastructure, this session will provide practical strategies to save time, reduce costs, and drive smarter industrial operations.
Presented by Scott Mangiacotti, Sr. Director, Automation Solutions at Cytiva

Soctt leads the global automation team at Cytiva, helping to design, code, document, and test the company’s next-generation computerized automation systems for the life sciences industry.
Scott joined Cytiva in 2009, and has since played a large role in designing the automation behind the Cytiva™Xcellerex™ single-use bioreactor platform and the Cytiva FlexFactory™ platform installation.
His professional career has spanned overlapping industries and multiple countries, including Germany, where lessons learned shaped his perspective on technology.
Scott holds multiple patents including one for the methods and apparatus to implement a flexible bioreactor control system. He earned his bachelor’s degree in electrical engineering and a master’s degree in information systems from Northeastern University in Boston.
Followed by a live Question and Answer session
Sponsored by Cytiva

At Cytiva, our mission is to advance and accelerate the development of therapeutics. With nearly 16,000 associates in more than 40 countries, we’re driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma, and contract manufacturers. Learn more at cytiva.com.
We will not sell your information to a third party. See our Privacy Policy